Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating lung disease characterized by irreversible scarring of the lungs. The cause of IPF is unknown, but it is thought to involve a combination of genetic and environmental factors. There is no cure for IPF, and trea...

Full description

Bibliographic Details
Main Authors: Dalia D. Hadi, Mohammed Dheyaa Marsool Marsool, Ali Dheyaa Marsool Marsool, Neel Vora, Sajjad G. Al‐Badri, Nabeel H. K. Al‐Fatlawi, Ameer F. Abbas Al Wssawi, Abdullah M. T. Al‐Ibraheem, Khadija A. Hamza, Priyadarshi Prajjwal, Mohammed A. Mateen, Omniat Amir
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Immunity, Inflammation and Disease
Subjects:
idiopathic pulmonary fibrosis
management
pulmonary hypertension
Sotatercept
Online Access:https://doi.org/10.1002/iid3.1079

Internet

https://doi.org/10.1002/iid3.1079

Similar Items